AstraZeneca (LSE:AZN)
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
About
Last updated 13-05-2021, 04:00:02pm BSTRelated Articles
-
Best stocks to buy: my money’s on AstraZeneca shares
In my basket of the best stocks to buy now, AstraZeneca shares feature prominently, considering the company's long-term outlook. Read More »
-
The AstraZeneca share price steadies: is this FTSE 100 stock a good investment?
The AstraZeneca share price is showing resilience in the face of disappointing vaccine publicity. This FTSE 100 stock has a lot to like. Read More »
-
2 FTSE 100 shares to buy right now
Rupert Hargreaves takes a look at a couple of his favourite FTSE 100 stocks he believes could be among the best shares to buy.... Read More »
-
Hit, hold or fold? Unilever, GlaxoSmithKline, AstraZeneca shares
If I had to buy, sell or hold AstraZeneca, Unilever or GlaxoSmithKline shares, what would I do? Fool UK contributor Joe Clark shows his... Read More »
-
AstraZeneca share price: back to sub-£70 levels. Should I buy now?
Do not let the AstraZeneca share price fool you. There is still much merit to the stock. Do the positives offset the negatives, though? Read More »
-
Stock market recovery: I’d invest in these 2 FTSE 100 shares today
FTSE 100 stocks B&M (LSE:BME) and AstraZeneca (LSE:AZN) are two of my top picks for long-term growth following this stock market recovery. Read More »
-
Shares to buy now: why I’d consider Lloyds Banking Group alongside this FTSE 100 stock
Since July, this FTSE 100 company's share price has been trending down. But the decline is at odds with the progress of the underlying... Read More »
-
AstraZeneca share price: is this FTSE 100 growth stock now a top ‘dip buy’?
The AstraZeneca share price has underperformed the FTSE 100 in recent months. G A Chester weighs up its dip-buy credentials. Read More »
-
The AstraZeneca share price: why I’d buy and hold the stock
The AstraZeneca share price has an attractive long-term outlook, thanks to its expansive portfolio of drugs and new treatments. Read More »
-
AstraZeneca: why I’m forgetting the headlines and following the trendlines
AstraZeneca is forging ahead with its portfolio of ‘on trend’ medicines that should prove increasingly profitable. Read More »